SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-24-076401
Filing Date
2024-06-28
Accepted
2024-06-28 17:24:03
Documents
5
Effectiveness Date
2024-06-28

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2417839d9_s8pos.htm S-8 POS 81815
2 EXHIBIT 5.1 tm2417839d9_ex5-1.htm EX-5.1 43355
3 EXHIBIT 23.1 tm2417839d9_ex23-1.htm EX-23.1 2110
4 GRAPHIC tm2417839d9_ex5-1img001.jpg GRAPHIC 3288
5 GRAPHIC tm2417839d9_ex5-1img002.jpg GRAPHIC 1481
  Complete submission text file 0001104659-24-076401.txt   135341
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-262971 | Film No.: 241087013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)